The red-blue COVID-19 death rate chasm apparently narrowed during the Omicron wave
The gap in total per capita COVID-19 deaths in Republican and Democratic counties has grown a lot wider since New York Times data journalist David Leonhardt chronicled the red-blue divide in November, at the beginning of the Omicron wave.
At the beginning of the pandemic, blue counties had higher death rates. "Only after the vaccines became widely available, in early 2021 — and liberals were much more willing to get shots than conservatives — did COVID become a disproportionately Republican illness," Leonhardt writes in Friday's Morning newsletter. "By the summer of 2021, the gap was soaring." But while the gap in cumulative deaths continues to expand, the growth the red-blue per capita death rate has slowed during the Omicron wave.
The most likely explanations for this narrowing death rate gap, Leonhardt writes, is "that the number of Trump voters vulnerable to severe illness — which was still very large earlier last year — has declined, because more of them have built up some immunity to COVID from a previous infection." But even with natural immunity, the COVID-19 dead are disproportionately unvaccinated or unboosted in red and blue counties alike. And the number of people dying each day is still tragically — unnecessarily — high.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
You can read more abut the red-blue gap at The New York Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Why does Elon Musk take his son everywhere?
Talking Point With his four-year-old 'emotional support human' by his side, what message is the world's richest man sending?
By Rebekah Evans, The Week UK Published
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published